Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Cheryl L. Rowe-Rendleman

ABSTRACT

In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused drug development (PFDD) tools used in ophthalmology. Since then numerous reports have been published which indicate that many of the questionnaires used for patient-reported outcomes (PROs) in ophthalmic clinical development lack rigor and reliability according to modern methods. In 2017, the FDA began development of a series of four methodological guidances for sponsors of clinical trials on the significance of PFDD. The new guidances delineate the FDA's thinking and commitments under the Prescription Drug User Fee Act to implement a more structured approach to the assessment of risks and benefits in clinical trials. In these guidances, the FDA provides steps that drug and device manufacturers should follow, not only to obtain, but also to develop reliable and validated tools that measure patients' experience in clinical trials. Subsequent efforts have resulted in the development and validation of PROs specifically for ophthalmology. The purpose of this paper is to assesses the PROs currently used in ophthalmology and to provide practical strategies for incorporating them into clinical trials. More... »

PAGES

54

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8

DOI

http://dx.doi.org/10.1007/s11095-019-2577-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112305511

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30790065


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Ophthalmic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Approval", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Compounding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Development", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Discovery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endpoint Determination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eye", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eye Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Government Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ocular Absorption", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ophthalmic Solutions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Reported Outcome Measures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Psychometrics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States Food and Drug Administration", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Ophthalmic Medical and Research Consulting, Omar Consulting Group, LLC, 08550, Princeton Junction, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rowe-Rendleman", 
        "givenName": "Cheryl L.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1167/iovs.05-1222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001512631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1008996223999", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002685260", 
          "https://doi.org/10.1023/a:1008996223999"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2010.143743", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003044413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2016.03.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005909588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2015.02.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007277525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.09-4494", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007961610"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.survophthal.2016.12.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008324392"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2007.06.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012051785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.11-7858", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014077478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5116/ijme.4dfb.8dfd", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015632748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2008.10.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016827406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1102673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018732383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2012.03.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018935436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcrs.2008.11.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020450222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1207/s15327752jpa8502_02", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025275661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1207/s15327752jpa8502_02", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025275661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s105536", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025433022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2011.12.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028796676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.10-5627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031778992"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcrs.2009.11.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031913828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.phrs.2015.11.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033277304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ico.0000000000000038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034919273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ico.0000000000000038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034919273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1542-0124(12)70081-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040875997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.118.5.615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041238167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa054481", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041610759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtos.2012.01.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042444231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61501-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043271928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjophthalmol-2014-306544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043598506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2014.41", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045327865", 
          "https://doi.org/10.1038/eye.2014.41"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/opx.0000000000000913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046741348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/opx.0000000000000913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046741348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaophthalmol.2016.2101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049230263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.07-0290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050790918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.119.7.1050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052734113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13548506.2016.1274040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058383148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2017.03.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084056752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/tvst.6.3.12", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085705016"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-018166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-018166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-018166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.oret.2018.01.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101289679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s168921", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106362561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtos.2018.11.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109779954"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused drug development (PFDD) tools used in ophthalmology. Since then numerous reports have been published which indicate that many of the questionnaires used for patient-reported outcomes (PROs) in ophthalmic clinical development lack rigor and reliability according to modern methods. In 2017, the FDA began development of a series of four methodological guidances for sponsors of clinical trials on the significance of PFDD. The new guidances delineate the FDA's thinking and commitments under the Prescription Drug User Fee Act to implement a more structured approach to the assessment of risks and benefits in clinical trials. In these guidances, the FDA provides steps that drug and device manufacturers should follow, not only to obtain, but also to develop reliable and validated tools that measure patients' experience in clinical trials. Subsequent efforts have resulted in the development and validation of PROs specifically for ophthalmology. The purpose of this paper is to assesses the PROs currently used in ophthalmology and to provide practical strategies for incorporating them into clinical trials.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11095-019-2577-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "name": "Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology", 
    "pagination": "54", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0b87970633fba698437ae88bd95891a05934e2c1264a0d80b425fd5855d46548"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30790065"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8406521"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11095-019-2577-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112305511"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11095-019-2577-8", 
      "https://app.dimensions.ai/details/publication/pub.1112305511"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000364_0000000364/records_72867_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11095-019-2577-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      88 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11095-019-2577-8 schema:about N0efdc61246864689b57abd3ae0eb2085
2 N1a6b6aa3ca3c4406ba3b951ae97f269c
3 N1f85de0ab3e84beeacbd1a8115cd385a
4 N2749a8607427431e973beb4cd372795a
5 N62ac698ab34c4e3d821b2a09514aa072
6 N7785ad11f283456a84f4a0d95d79cbf2
7 N9bf44d66c969461e8715b79386564982
8 N9e375d90fb8044349dba8d0788968da3
9 Na5fc86fabe0c4666b0cc4520edfd4824
10 Nbdd23c3482b444b4bf95a2b70e7a9700
11 Nbfa91ae496cd4f5eb4498ef2c1df3d54
12 Nc266bc310c494d7183d38682aca0fa03
13 Nd253c2147260423ab996d019bd727872
14 Ndab2c13a1c07457cbc0908b489e1638c
15 Ndc262ae2bc0d4bb3ab327e828e143b0d
16 Ne5d10715b709438197e81727b613cef7
17 Ne80c9abdf8114463a61e3e05cdfd5c47
18 Neeed5d81e3414771adc164e466664f87
19 Nf090fe9568d4429fb12994fde9b11b9f
20 Nf9fd166281d64b0cb9246f8da2e9a014
21 anzsrc-for:11
22 anzsrc-for:1117
23 schema:author Necbd0b07ac6d4d428791594fd94ff06e
24 schema:citation sg:pub.10.1023/a:1008996223999
25 sg:pub.10.1038/eye.2014.41
26 https://doi.org/10.1001/archopht.118.5.615
27 https://doi.org/10.1001/archopht.119.7.1050
28 https://doi.org/10.1001/jamaophthalmol.2016.2101
29 https://doi.org/10.1016/j.ajo.2007.06.012
30 https://doi.org/10.1016/j.ajo.2017.03.009
31 https://doi.org/10.1016/j.jcrs.2008.11.038
32 https://doi.org/10.1016/j.jcrs.2009.11.019
33 https://doi.org/10.1016/j.jtos.2012.01.007
34 https://doi.org/10.1016/j.jtos.2018.11.003
35 https://doi.org/10.1016/j.ophtha.2008.10.018
36 https://doi.org/10.1016/j.ophtha.2011.12.016
37 https://doi.org/10.1016/j.ophtha.2012.03.053
38 https://doi.org/10.1016/j.ophtha.2015.02.037
39 https://doi.org/10.1016/j.ophtha.2016.03.045
40 https://doi.org/10.1016/j.oret.2018.01.006
41 https://doi.org/10.1016/j.phrs.2015.11.027
42 https://doi.org/10.1016/j.survophthal.2016.12.011
43 https://doi.org/10.1016/s0140-6736(13)61501-9
44 https://doi.org/10.1016/s1542-0124(12)70081-2
45 https://doi.org/10.1056/nejmoa054481
46 https://doi.org/10.1056/nejmoa1102673
47 https://doi.org/10.1080/13548506.2016.1274040
48 https://doi.org/10.1097/ico.0000000000000038
49 https://doi.org/10.1097/opx.0000000000000913
50 https://doi.org/10.1136/ard.2010.143743
51 https://doi.org/10.1136/bjophthalmol-2014-306544
52 https://doi.org/10.1136/bmjopen-2017-018166
53 https://doi.org/10.1167/iovs.05-1222
54 https://doi.org/10.1167/iovs.07-0290
55 https://doi.org/10.1167/iovs.09-4494
56 https://doi.org/10.1167/iovs.10-5627
57 https://doi.org/10.1167/iovs.11-7858
58 https://doi.org/10.1167/tvst.6.3.12
59 https://doi.org/10.1207/s15327752jpa8502_02
60 https://doi.org/10.2147/ppa.s105536
61 https://doi.org/10.2147/ppa.s168921
62 https://doi.org/10.5116/ijme.4dfb.8dfd
63 schema:datePublished 2019-04
64 schema:datePublishedReg 2019-04-01
65 schema:description In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused drug development (PFDD) tools used in ophthalmology. Since then numerous reports have been published which indicate that many of the questionnaires used for patient-reported outcomes (PROs) in ophthalmic clinical development lack rigor and reliability according to modern methods. In 2017, the FDA began development of a series of four methodological guidances for sponsors of clinical trials on the significance of PFDD. The new guidances delineate the FDA's thinking and commitments under the Prescription Drug User Fee Act to implement a more structured approach to the assessment of risks and benefits in clinical trials. In these guidances, the FDA provides steps that drug and device manufacturers should follow, not only to obtain, but also to develop reliable and validated tools that measure patients' experience in clinical trials. Subsequent efforts have resulted in the development and validation of PROs specifically for ophthalmology. The purpose of this paper is to assesses the PROs currently used in ophthalmology and to provide practical strategies for incorporating them into clinical trials.
66 schema:genre research_article
67 schema:inLanguage en
68 schema:isAccessibleForFree false
69 schema:isPartOf N3c7e88776ba74ac8ae412cfc212a8d8b
70 Nbcf07a875a8f49fab9a698e6f65ad3fd
71 sg:journal.1094644
72 schema:name Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
73 schema:pagination 54
74 schema:productId N142239f1d060400cb0d5d75c8c6baebb
75 N5b25029ec2e140229a8dc5414950c20b
76 N5ceb1485fb74415d97da74cba572ac3d
77 Na0da69eb46e34f278805e1276b10da4e
78 Ne659310a514344d3a1db53e8eceef8c7
79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112305511
80 https://doi.org/10.1007/s11095-019-2577-8
81 schema:sdDatePublished 2019-04-11T12:55
82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
83 schema:sdPublisher N917ddeba818f4712922dc9227ffe77bd
84 schema:url https://link.springer.com/10.1007%2Fs11095-019-2577-8
85 sgo:license sg:explorer/license/
86 sgo:sdDataset articles
87 rdf:type schema:ScholarlyArticle
88 N0efdc61246864689b57abd3ae0eb2085 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Ocular Absorption
90 rdf:type schema:DefinedTerm
91 N142239f1d060400cb0d5d75c8c6baebb schema:name pubmed_id
92 schema:value 30790065
93 rdf:type schema:PropertyValue
94 N1a6b6aa3ca3c4406ba3b951ae97f269c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Eye
96 rdf:type schema:DefinedTerm
97 N1f85de0ab3e84beeacbd1a8115cd385a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Clinical Trials as Topic
99 rdf:type schema:DefinedTerm
100 N2749a8607427431e973beb4cd372795a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Treatment Outcome
102 rdf:type schema:DefinedTerm
103 N3c7e88776ba74ac8ae412cfc212a8d8b schema:volumeNumber 36
104 rdf:type schema:PublicationVolume
105 N5b25029ec2e140229a8dc5414950c20b schema:name dimensions_id
106 schema:value pub.1112305511
107 rdf:type schema:PropertyValue
108 N5ceb1485fb74415d97da74cba572ac3d schema:name nlm_unique_id
109 schema:value 8406521
110 rdf:type schema:PropertyValue
111 N62ac698ab34c4e3d821b2a09514aa072 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Patient Safety
113 rdf:type schema:DefinedTerm
114 N7785ad11f283456a84f4a0d95d79cbf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Endpoint Determination
116 rdf:type schema:DefinedTerm
117 N917ddeba818f4712922dc9227ffe77bd schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N9bf44d66c969461e8715b79386564982 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Drug Development
121 rdf:type schema:DefinedTerm
122 N9e375d90fb8044349dba8d0788968da3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Risk Assessment
124 rdf:type schema:DefinedTerm
125 Na0da69eb46e34f278805e1276b10da4e schema:name doi
126 schema:value 10.1007/s11095-019-2577-8
127 rdf:type schema:PropertyValue
128 Na5fc86fabe0c4666b0cc4520edfd4824 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Patient Reported Outcome Measures
130 rdf:type schema:DefinedTerm
131 Nbcf07a875a8f49fab9a698e6f65ad3fd schema:issueNumber 4
132 rdf:type schema:PublicationIssue
133 Nbdd23c3482b444b4bf95a2b70e7a9700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Psychometrics
135 rdf:type schema:DefinedTerm
136 Nbfa91ae496cd4f5eb4498ef2c1df3d54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name United States Food and Drug Administration
138 rdf:type schema:DefinedTerm
139 Nc266bc310c494d7183d38682aca0fa03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Eye Diseases
141 rdf:type schema:DefinedTerm
142 Nc9060e4bbb8d4c21b5c03689071e91cc schema:name Ophthalmic Medical and Research Consulting, Omar Consulting Group, LLC, 08550, Princeton Junction, NJ, USA
143 rdf:type schema:Organization
144 Nc95915fb436b411cb27d469af59e3e59 schema:affiliation Nc9060e4bbb8d4c21b5c03689071e91cc
145 schema:familyName Rowe-Rendleman
146 schema:givenName Cheryl L.
147 rdf:type schema:Person
148 Nd253c2147260423ab996d019bd727872 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name United States
150 rdf:type schema:DefinedTerm
151 Ndab2c13a1c07457cbc0908b489e1638c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Drug Approval
153 rdf:type schema:DefinedTerm
154 Ndc262ae2bc0d4bb3ab327e828e143b0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Drug Discovery
156 rdf:type schema:DefinedTerm
157 Ne5d10715b709438197e81727b613cef7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Drug Compounding
159 rdf:type schema:DefinedTerm
160 Ne659310a514344d3a1db53e8eceef8c7 schema:name readcube_id
161 schema:value 0b87970633fba698437ae88bd95891a05934e2c1264a0d80b425fd5855d46548
162 rdf:type schema:PropertyValue
163 Ne80c9abdf8114463a61e3e05cdfd5c47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Ophthalmic Solutions
165 rdf:type schema:DefinedTerm
166 Necbd0b07ac6d4d428791594fd94ff06e rdf:first Nc95915fb436b411cb27d469af59e3e59
167 rdf:rest rdf:nil
168 Neeed5d81e3414771adc164e466664f87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Government Regulation
170 rdf:type schema:DefinedTerm
171 Nf090fe9568d4429fb12994fde9b11b9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Administration, Ophthalmic
173 rdf:type schema:DefinedTerm
174 Nf9fd166281d64b0cb9246f8da2e9a014 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Humans
176 rdf:type schema:DefinedTerm
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
181 schema:name Public Health and Health Services
182 rdf:type schema:DefinedTerm
183 sg:journal.1094644 schema:issn 0724-8741
184 1573-904X
185 schema:name Pharmaceutical Research
186 rdf:type schema:Periodical
187 sg:pub.10.1023/a:1008996223999 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002685260
188 https://doi.org/10.1023/a:1008996223999
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/eye.2014.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045327865
191 https://doi.org/10.1038/eye.2014.41
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1001/archopht.118.5.615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041238167
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1001/archopht.119.7.1050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052734113
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1001/jamaophthalmol.2016.2101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049230263
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/j.ajo.2007.06.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012051785
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/j.ajo.2017.03.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084056752
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.jcrs.2008.11.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020450222
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.jcrs.2009.11.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031913828
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/j.jtos.2012.01.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042444231
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/j.jtos.2018.11.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109779954
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/j.ophtha.2008.10.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016827406
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/j.ophtha.2011.12.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028796676
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.ophtha.2012.03.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018935436
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/j.ophtha.2015.02.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007277525
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/j.ophtha.2016.03.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005909588
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.oret.2018.01.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101289679
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.phrs.2015.11.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033277304
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.survophthal.2016.12.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008324392
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0140-6736(13)61501-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043271928
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/s1542-0124(12)70081-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040875997
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1056/nejmoa054481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041610759
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1056/nejmoa1102673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018732383
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1080/13548506.2016.1274040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058383148
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1097/ico.0000000000000038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034919273
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1097/opx.0000000000000913 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046741348
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1136/ard.2010.143743 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003044413
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1136/bjophthalmol-2014-306544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043598506
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1136/bmjopen-2017-018166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101034366
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1167/iovs.05-1222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001512631
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1167/iovs.07-0290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050790918
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1167/iovs.09-4494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007961610
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1167/iovs.10-5627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031778992
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1167/iovs.11-7858 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014077478
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1167/tvst.6.3.12 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085705016
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1207/s15327752jpa8502_02 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025275661
260 rdf:type schema:CreativeWork
261 https://doi.org/10.2147/ppa.s105536 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025433022
262 rdf:type schema:CreativeWork
263 https://doi.org/10.2147/ppa.s168921 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106362561
264 rdf:type schema:CreativeWork
265 https://doi.org/10.5116/ijme.4dfb.8dfd schema:sameAs https://app.dimensions.ai/details/publication/pub.1015632748
266 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...